Provided by Tiger Trade Technology Pte. Ltd.

Edesa Biotech

1.12
0.0000
Post-market: 1.120.00000.00%16:04 EST
Volume:53.11K
Turnover:59.01K
Market Cap:9.33M
PE:-0.88
High:1.17
Open:1.10
Low:1.06
Close:1.12
52wk High:4.49
52wk Low:0.9404
Shares:8.33M
Float Shares:4.28M
Volume Ratio:0.22
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2658
EPS(LYR):-1.2658
ROE:-99.57%
ROA:-57.02%
PB:2.92
PE(LYR):-0.88

Loading ...

Skin drug developer Edesa Biotech's FY net loss widens to $7.2 mln

Reuters
·
Dec 13, 2025

Edesa Biotech Q4 EPS $(0.32) Misses $(0.27) Estimate

Benzinga
·
Dec 13, 2025

Edesa Biotech Inc. reports FY research and development expenses of USD 3.7 million, up 27%

Reuters
·
Dec 13, 2025

Edesa Biotech FY Operating Expenses USD 7.9 Million

THOMSON REUTERS
·
Dec 13, 2025

Press Release: Edesa Biotech Reports Fiscal Year 2025 Results

Dow Jones
·
Dec 13, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Dec 11, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Dec 08, 2025

Edesa Biotech (EDSA) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Nov 04, 2025

Edesa Biotech Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
Nov 04, 2025

Edesa Biotech to Participate in Key Industry Conferences

TIPRANKS
·
Nov 01, 2025

Edesa Biotech Announces Upcoming Conference Schedule

GlobeNewswire
·
Nov 01, 2025

BRIEF-Edesa Biotech Reports Positive Results In Phase 3 Respiratory Study

Reuters
·
Oct 28, 2025

Edesa Biotech Reports Positive Phase 3 Results for ARDS Drug Paridiprubart

Reuters
·
Oct 28, 2025

Edesa Biotech Inc - Paridiprubart Shows 25% Reduction in Risk of Death

THOMSON REUTERS
·
Oct 28, 2025

Edesa Biotech Inc - Eb05 Well-Tolerated in Safety Population of Over 275 Subjects

THOMSON REUTERS
·
Oct 28, 2025

Edesa Biotech Inc: Study Met Primary and Secondary Endpoints

THOMSON REUTERS
·
Oct 28, 2025

Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment

TIPRANKS
·
Oct 28, 2025

Edesa Biotech Amends $23 Million Funding Agreement with Government of Canada, Extends Repayment Timeline and Expands ARDS Drug Focus

Reuters
·
Oct 01, 2025

Edesa Biotech Inc. Files Prospectus for $4 Million At-The-Market Offering Program

Reuters
·
Sep 10, 2025

Edesa Biotech Q3 loss per share narrows

Reuters
·
Aug 09, 2025